Hofseth BioCare lands NDI for peptides, completing the portfolio of human food-grade ingredients

Related Articles

FormattedPicture

FOOD RESEARCH

US-based researchers have found a high likelihood that some of the most popular baby products in supermarkets – rice cereals, infant formula, puffs and purees... Read More

FormattedPicture

REGULATORY NEWS

The US Food and Drug Administration (FDA) is undergoing significant changes to modernize and consolidate its programs, including building a more robust regulatory... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nutrition R&D innovator Hofseth BioCare has received attention for its salmon-derived protein hydrolysate powder and its salmon fish oil OmeGo, featuring 21 fatty... Read More

FormattedPicture

REGULATORY NEWS

The US Food and Drug Administration (FDA) has said no to three different citizen petitions requesting that cannabidiol (CBD) products be marketed as dietary supplements.... Read More

FormattedPicture

REGULATORY NEWS

The US Food and Drug Administration (FDA) has issued draft guidance for the baby food industry regarding lead in processed foods intended for infants, babies and... Read More

trans